| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | -14.8% | — |
| R&D Expense | $18.5M | -6.7% | -7.5% |
| SG&A Expense | $6.7M | -9.0% | +41.2% |
| Operating Income | -$23.1M | +6.6% | +6.5% |
| Net Income | -$20.2M | +6.5% | +13.8% |
| EPS (Basic) | -$0.56 | +6.7% | +91.6% |
| EPS (Diluted) | -$0.56 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $215.6M | -2.2% | -35.5% |
| Short-term Investments | $70.2M | -8.8% | — |
| Accounts Receivable | $515K | -14.6% | — |
| Current Assets | $290.8M | -3.6% | -13.6% |
| Total Assets | $305.1M | -5.3% | -9.6% |
| Current Liabilities | $24.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.4M | — | — |
| Capital Expenditures | $607K | — | — |
| Investing Cash Flow | -$80.8M | — | — |
| Financing Cash Flow | -$4.5M | — | — |
| Free Cash Flow | -$54.0M | — | — |
| +91.6% |
| +7.3% |
| +28.4% |
| Long-term Debt | $0 | — | -100.0% |
| Total Liabilities | $27.6M | +0.9% | +16.9% |
| Stockholders' Equity | $277.5M | -5.9% | -11.6% |